Clinical Trials Browser

OTHER_GOV × Interventional × Laryngeal Neoplasms × Clear all

NCT06554028 2024-08-14

Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer

Phase 2 Not yet recruiting

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT00128817 2013-01-23

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Phase 3 Terminated

Laryngeal Diseases, Laryngeal Neoplasms, Neoplasms